论文部分内容阅读
急性白血病(以下简称急白)是一种比较常见的恶性血液病。本病主要侵犯儿童及青壮年,病死率甚高。近年来,由于治疗方法的改进及新的化疗药的使用,缓解率显著提高,生存期明显延长,预后已大为改观。据国外报道,儿童急白完全缓解率达90%以上,生存期达5年以上者占50%,其中部分病例属于治愈。成人急白预后较差,但经合理治疗,约50～75%亦可获完全缓解,其中近四分之一生存超过2年,少数可以长期存活。目前认为,许多因素可影响本病的治疗结果及预后,现将
Acute leukemia (hereinafter referred to as emergency white) is a more common hematological malignancy. The disease mainly infants and young adults, the case fatality rate is very high. In recent years, due to the improvement of treatment methods and the use of new chemotherapeutic drugs, the remission rate was significantly improved, the survival period was significantly prolonged, the prognosis has been greatly improved. According to foreign reports, children with acute white complete remission rate of 90% or more, survival of more than 5 years accounted for 50%, of which some cases are cured. In acute exacerbation, the prognosis of adults is poor, but about 50-75% of the patients can be completely relieved after reasonable treatment. Nearly one-quarter of them survive more than 2 years and a few of them can survive long-term. At present, many factors can affect the treatment outcome and prognosis of the disease, now